Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $10.4 Million - $11.9 Million
71,200 Added 474.67%
86,200 $14 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $2.02 Million - $2.21 Million
14,000 Added 1400.0%
15,000 $2.19 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $3.26 Million - $3.42 Million
-21,000 Reduced 95.45%
1,000 $158,000
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $509,600 - $556,080
-3,500 Reduced 13.73%
22,000 $3.45 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $856,625 - $959,640
-5,500 Reduced 17.74%
25,500 $3.97 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $2.47 Million - $2.66 Million
16,000 Added 106.67%
31,000 $5.13 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $755,250 - $901,300
5,000 Added 50.0%
15,000 $2.33 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $806,650 - $897,600
5,000 Added 100.0%
10,000 $1.63 Million
Q2 2022

Aug 17, 2022

SELL
$168.19 - $186.01 $840,950 - $930,050
-5,000 Reduced 50.0%
5,000 $888,000
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $1.58 Million - $1.8 Million
10,000 New
10,000 $1.77 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $9.18 Million - $10.1 Million
-65,400 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $1.82 Million - $2.19 Million
-14,100 Reduced 17.74%
65,400 $9.2 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $633,498 - $877,743
-5,700 Reduced 6.69%
79,500 $10.4 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $10.9 Million - $12.5 Million
85,200 New
85,200 $12.4 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $9.73 Million - $11.4 Million
-80,000 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$119.4 - $131.76 $9.55 Million - $10.5 Million
80,000 New
80,000 $9.71 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.